Gastrointestinal Cancers

Steven J. Cohen MD and Alan P. Venook MD review and share their expert perspectives on key GI cancer findings presented at the 2017 American Society of Clinical Oncology Annual Meeting.

Share

Program Content

Activities

  • REFLECT: Lenvatinib in uHCC
    REFLECT: Phase III Noninferiority Study of the Multikinase Inhibitor Lenvatinib vs Sorafenib as First-line Therapy in Unresectable Hepatocellular Carcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2017

    Expires: June 04, 2018

  • IDEA: Adjuvant Oxaliplatin in Colon Cancer
    IDEA: Pooled Analysis of Adjuvant Oxaliplatin for 3 vs 6 Mos in Stage III Colon Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2017

    Expires: June 04, 2018

  • AG-120 in IDH1-Mutant CC
    Safety and Clinical Activity of Mutant IDH1 Inhibitor AG-120 in Pretreated IDH1-Mutant Cholangiocarcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 06, 2017

    Expires: June 05, 2018

  • HALO-202: PEGPH20 in Pancreatic
    Phase II HALO-202: nab-Paclitaxel and Gemcitabine ± PEGPH20 in Untreated Metastatic Pancreatic Ductal Adenocarcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 06, 2017

    Expires: June 05, 2018

  • SIRveNIB: SIRT vs Sorafenib in HCC
    SIRveNIB: Randomized Phase III Trial of Selective Internal Radiation Therapy vs Sorafenib in Locally Advanced HCC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2017

    Expires: June 06, 2018

  • BILCAP
    BILCAP: Phase III Trial of Adjuvant Capecitabine for Biliary Tract Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2017

    Expires: June 06, 2018

  • ASPECCT: ctDNA Analysis
    Circulating Tumor DNA Analysis From Pts With mCRC Who Were Treated With Panitumumab in ASPECCT
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2017

    Expires: June 07, 2018

  • mCRC: Vemurafenib Combination
    SWOG S1406: Vemurafenib in Combination With Irinotecan and Cetuximab in BRAF V600E Metastatic CRC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 12, 2017

    Expires: June 11, 2018

  • KEYNOTE-059: Pembro in G/GEJ Cancer
    KEYNOTE-059 (Cohort 1): Pembrolizumab Monotherapy in Previously Treated Advanced Gastric or GEJ Adenocarcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 13, 2017

    Expires: June 12, 2018

  • Prognostic Markers in CRC
    Prognostic Factors for First-line Chemotherapy + Bevacizumab or Cetuximab in Metastatic Colorectal Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 14, 2017

    Expires: June 13, 2018

Provided by

ProCE Banner

Supporters

AbbVie

Amgen, Inc.

AstraZeneca

Celgene

Genentech Roche Virology

Halozyme

Incyte

Merck Oncology